Sarah P. Psutka

Subcutaneous Fat Is Associated with Improved Survival in Patients with Non-Metastatic Clear Cell Renal Cell Carcinoma: Dissecting the Obesity Paradox.

Journal: Cancers

Published: July 14, 2026

The impact of cachexia and sarcopenia in bladder cancer.

Journal: Current opinion in supportive and palliative care

Published: July 08, 2026

Epidemiology and Risk Factors for Non-Muscle-Invasive Bladder Cancer: Insights into Prevalence, Risk Stratification, and Implications for Early Diagnosis.

Journal: The Urologic clinics of North America

Published: June 26, 2026

Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.04.008.

Journal: European urology oncology

Published: June 07, 2026

Safety, Hemostasis, and Surgical Precision: Reconsidering Tranexamic Acid in Contemporary Urologic Surgery.

Journal: European urology

Published: May 06, 2026

Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Journal: Nature reviews. Urology

Published: March 11, 2026

Bacillus Calmette-Guérin (BCG) and Beyond: Is Systemic Immunotherapy for BCG-Naïve Non-Muscle-Invasive Bladder Cancer Progress or Overreach?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 02, 2026

Sarcopenia is associated with poor survival among patients with non-metastatic renal cell carcinoma and venous tumor thrombus.

Journal: World journal of urology

Published: February 16, 2026

Radiosurgery in Upper Tract Urothelial Carcinoma (UTUC).

Journal: Cancers

Published: February 11, 2026

Exercise, nutrition, and psychological support for kidney cancer: a scoping review.

Journal: BJU international

Published: January 19, 2026

Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Subcutaneous Fat Is Associated with Improved Survival in Patients with Non-Metastatic Clear Cell Renal Cell Carcinoma: Dissecting the Obesity Paradox.

Subcutaneous Fat Is Associated with Improved Survival in Patients with Non-Metastatic Clear Cell Renal Cell Carcinoma: Dissecting the Obesity Paradox.

The impact of cachexia and sarcopenia in bladder cancer.

The impact of cachexia and sarcopenia in bladder cancer.

Epidemiology and Risk Factors for Non-Muscle-Invasive Bladder Cancer: Insights into Prevalence, Risk Stratification, and Implications for Early Diagnosis.

Epidemiology and Risk Factors for Non-Muscle-Invasive Bladder Cancer: Insights into Prevalence, Risk Stratification, and Implications for Early Diagnosis.

Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.04.008.

Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.04.008.

Safety, Hemostasis, and Surgical Precision: Reconsidering Tranexamic Acid in Contemporary Urologic Surgery.

Safety, Hemostasis, and Surgical Precision: Reconsidering Tranexamic Acid in Contemporary Urologic Surgery.

Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Bacillus Calmette-Guérin (BCG) and Beyond: Is Systemic Immunotherapy for BCG-Naïve Non-Muscle-Invasive Bladder Cancer Progress or Overreach?

Bacillus Calmette-Guérin (BCG) and Beyond: Is Systemic Immunotherapy for BCG-Naïve Non-Muscle-Invasive Bladder Cancer Progress or Overreach?

Sarcopenia is associated with poor survival among patients with non-metastatic renal cell carcinoma and venous tumor thrombus.

Sarcopenia is associated with poor survival among patients with non-metastatic renal cell carcinoma and venous tumor thrombus.

Radiosurgery in Upper Tract Urothelial Carcinoma (UTUC).

Radiosurgery in Upper Tract Urothelial Carcinoma (UTUC).

Exercise, nutrition, and psychological support for kidney cancer: a scoping review.

Exercise, nutrition, and psychological support for kidney cancer: a scoping review.

Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results.

Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results.

SunRISe-4 perioperative safety and TURBT stratification - Authors' reply.

SunRISe-4 perioperative safety and TURBT stratification - Authors' reply.